Welcome to LookChem.com Sign In|Join Free

CAS

  • or

61940-22-5

Post Buying Request

61940-22-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

61940-22-5 Usage

Uses

2-Methyl-6-nitrobenzoic Acid Methyl Ester is an ester derivative of 2-Methyl-nitrobenzoic Acid (M325545), an derivative of Anthranilic Acid (A679220).

Check Digit Verification of cas no

The CAS Registry Mumber 61940-22-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,9,4 and 0 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 61940-22:
(7*6)+(6*1)+(5*9)+(4*4)+(3*0)+(2*2)+(1*2)=115
115 % 10 = 5
So 61940-22-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H9NO4/c1-6-4-3-5-7(10(12)13)8(6)9(11)14-2/h3-5H,1-2H3

61940-22-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 2-methyl-6-nitrobenzoate

1.2 Other means of identification

Product number -
Other names 2-methyl-6-nitro-benzoic acid methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:61940-22-5 SDS

61940-22-5Relevant articles and documents

CHEMICAL COMPOUNDS

-

Paragraph 0570-0571, (2021/01/23)

The present disclosure describes novel compounds, or their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and their medical uses. Compounds of the disclosure have activity as dual modulators of Janus kinase (JAK), alone, or in combination with one or more of an additional mechanism, including a tyrosine kinase, such as TrkA or Syk, and PDE4, and are useful in the in the treatment or control of inflammation, auto-immune diseases, cancer, and other disorders and indications where modulation of JAK would be desirable. Also described herein are methods of treating inflammation, auto-immune diseases, cancer, and other conditions susceptible to inhibition of JAK and PDE4 by administering a compound herein described.

Compound containing benzotriazinone structure, preparation method and application thereof, and herbicide

-

Paragraph 0123-0125, (2020/12/30)

The invention relates to the field of pesticide compounds, and discloses a compound containing a benzotriazinone structure, a preparation method and application thereof, and a herbicide, and the compound has a structure represented by a formula (I). The c

NOVEL PIPERIDINE-2,6-DIONE DERIVATIVE AND USE THEREOF

-

Paragraph 0202-0203, (2020/03/09)

The present disclosure relates to a novel piperidine-2,6-dione derivative and a use thereof and, more specifically, to a piperidine-2,6-dione derivative compound having a structure of a thalidomide analog. A compound of chemical formula 1 according to the present disclosure specifically binds with CRBN protein, and is involved in functions thereof. Therefore, the compound of the present disclosure can be favorably used in the prevention or treatment of leprosy, chronic graft versus host disease, an inflammatory disease, or cancer, which are caused by actions of CRBN protein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 61940-22-5